Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cancer Vaccines

Known as: vaccines cancer, Tumor Vaccine, Cancer Vaccines [Chemical/Ingredient] 
Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Recent advances in several areas are rekindling interest and enabling progress in the development of therapeutic cancer vaccines… Expand
  • figure 1
  • figure 2
Is this relevant?
Review
2016
Review
2016
In recent years immunotherapy has revolutionized the treatment of patients with advanced cancer. The increased knowledge in the… Expand
Is this relevant?
Highly Cited
2015
Highly Cited
2015
Cyclic dinucleotide formulated cancer vaccine combined with PD-1 blockade can induce regression of tumors that do not express PD… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
IMA901 is the first therapeutic vaccine for renal cell cancer (RCC) consisting of multiple tumor-associated peptides (TUMAPs… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
The purpose of the National Cancer Institute pilot project to prioritize cancer antigens was to develop a well-vetted, priority… Expand
  • table 1
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Review
2007
Review
2007
  • Eli Gilboa
  • The Journal of clinical investigation
  • 2007
  • Corpus ID: 36402322
Because of the large preexisting antigenic load and immunosuppressive environment within a tumor, inducing therapeutically useful… Expand
  • figure 1
  • figure 2
Is this relevant?
Review
2005
Review
2005
Cancer/testis (CT) antigens, of which more than 40 have now been identified, are encoded by genes that are normally expressed… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Unmet needs across the oncology market remain high, with most traditional therapies representing a trade-off between levels of… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Great progress has been made in the field of tumor immunology in the past decade, but optimism about the clinical application of… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2003
Review
2003
Whether vaccines are designed to prepare the immune system for the encounter with a pathogen or with cancer, certain common… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?